CBD Life Sciences, Inc. (CBDL) Announces Significant Increase in CBD Production Following Inventory Demand Through Online Sales

Step onto Wall Street with StreetInsider Premium. Request your one-week free trial here.

SCOTTSDALE, AZ / ACCESSWIRE / September 14, 2021 / CBD Life Sciences (OTC PINK: CBDL) today announced, through its wholly-owned subsidiary LBC Bioscience Inc., that the company has started increasing its production rate of CBD-based products in response to stronger than expected e-commerce demand for its Amazon – and new website launch together with Alibaba soon.

CBD Life Sciences Inc. is excited to update and continue to expand its e-commerce platform to strengthen its digital presence and drive further revenue growth in response to this strong market response. President & CEO Lisa Nelson says, “We have seen tremendous market response as we expand our e-commerce sales activities and our main concern right now is creating shareholder value, which means we are ready to use this channel over the course of the year Time to keep expanding. ” continues! “Lisa Nelson also said:” After all the investments we have made in this process, it is great to see that everything is going as we want it to and that the product leaves the door immediately. “

Ms. Nelson continued, “The fact that our product is selling faster than expected is a big problem and we know exactly how to deal with it. What opportunities are on the road ahead!”

CBD Life Sciences Inc. once again plans to dominate the industry by further expanding its products to large platforms, and this time around, CBD is adding Alibaba to the list. The products that will be available on Alibaba will be edibles, cartridges, and many different tinctures that CBD Life Sciences Inc. is currently developing and creating to complement the existing line of products.

B2B e-commerce refers to the exchange of goods and services between companies via online platforms. While the use of digital channels has traditionally been limited to B2C companies, consumer brands, and retail transactions, there have also been great digital advances and unprecedented adoption of e-commerce solutions in the B2B landscape in recent years. In 2019, the global gross goods volume (GMV) in B2B e-commerce was $ 12.2 trillion, up from around $ 5.83 trillion in 2013. This rapid growth in global B2B e-commerce Area not only reflects the advancing digitization of the world commerce, but also signals the consistent digital restructuring of the B2B market worldwide. Ultimately, according to Forrester, US business-to-business (B2B) e-commerce transactions are expected to reach $ 1.8 trillion by 2023. That would represent 17% of all B2B sales in the country.

CBD Life Sciences Inc. is approaching its third retail location along with a marijuana recreational facility. This will matter in terms of expansion and sales, and CBD Life Sciences Inc. will keep the public informed about the future.

The number of benefits of CBD is enormous! These benefits include helping with behavioral / neurological complications such as ADD / ADHD, anxiety, bipolar disorder, obsessive-compulsive disorder, PTSD, epilepsy, Parkinson’s, osteoporosis, and ALS. CBD can also help treat pain that can result from headaches / migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD also has gastrointestinal benefits for gastrointestinal disorders and complications such as anorexia, cachexia, Crohn’s disease, diabetes, and nausea. Physical complications / disorders like muscular dystrophy and even immune system-based deficiencies and other complications like cancer and high blood pressure, even our bodies’ way and ability to maintain homeostasis, are all supposed to benefit from CBD.

LBC BIOSCIENCE INC. ONLINE SHOP

The online emporium of LBC BIOSCIENCE

LBC Bioscience Inc. is already well stocked with some very high quality CBD offerings – all at very affordable prices. Check out the latest product offerings from LBC Bioscience Inc including: 100 MG CBD Bath Bombs in Various Fragrances, Delta 8 Gummies, 1500 MG Premium Berry Drops and a variety of brand new skin care products. Or, buy our best-selling products (based on order frequency) including our CBD Pain Cream, CBD Oils, and CBD Pet Treats.

Become a sales partner

Large product selection (over 50 items and growing)

100% “organic & kosher” products made in the USA.

All products are THC-FREE (they contain 0.00% THC)

Weekly offers (new offers every week)

25% discount on all products with code “LBC25”.

LBC Bioscience Inc. accepts: Visa, MasterCard, American Express, Discover, etc.

Shareholders and shareholders can also keep up to date with updates from LBC Bioscience Inc:

Main LBC Bioscience Inc website at www.lbcbioscienceinc.com
Twitter: https://www.twitter.com/lbcbioscience
Facebook: https://www.facebook.com/lbcbioscience
Instagram: https://www.instagram.com/lbcbioscience

Amazon: https://www.amazon.com/shops/lbcbioscienceinc

About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and retailed a full line of cannabidiol-based organic products, including CBD drops, chewing gum, honey sticks, pain relief creams, anxiety and sleep supplements, edibles , Coffee, skin care line, pet line, tablets and more. LBC’s products can be viewed and purchased on the company’s website at www.lbcbioscienceinc.com.

Ten Associates LLC
Contact: Thomas E. Nelson
Phone: (480) 326-8577
Email: tenassociates33@gmail.com
Website: www.tenassociatesllc.com

Forward-Looking Statements

Other than the historical information contained herein, the topics discussed in this press release are forward-looking statements. Actual results could differ materially from those described in the forward-looking statements and are subject to risks and uncertainties. Refer to the filings of CBD Life Sciences, Inc., Inc. with OTC Markets for information about specific factors that could cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement

This press release contains forward-looking statements that are based on certain assumptions and reflect management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, industry changes and growth rates; Uncertainty as to whether our strategies and business plans will bring the expected benefits; increasing competition; Availability and cost of capital; the ability to identify and develop and achieve commercial success; the amount of expenditure required to maintain and improve the quality of services; Changes in the economy; Changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other unexpected matters; our ability to secure and maintain strategic relationships and distribution agreements. The company disclaims any intention or obligation to update or revise any forward-looking capabilities for securing and maintaining strategic relationships and distribution agreements. The company disclaims any intention or obligation to update or revise any forward-looking information

SOURCE: CBD Life Sciences Inc.

View source version on accesswire.com:
https://www.accesswire.com/663855/CBD-Life-Sciences-Inc-CBDL-Announces-Significant-Increase-in-CBD-Production-Following-Inventory-Demand-Through-Online-Sales

source https://www.bisayanews.com/2021/09/14/cbd-life-sciences-inc-cbdl-announces-significant-increase-in-cbd-production-following-inventory-demand-through-online-sales/